Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

다국어 초록 (Multilingual Abstract)

Recent developments in imaging technology, radiotherapeutic approaches, biological target therapy, and increased use of minimally invasive surgery have drastically changed the paradigm for management of women with cervical cancer. Until now, the International Federation of Gynecology and Obstetrics (FIGO) staging system was based primarily on clinical examination with limited additional diagnostic procedures allowed by the FIGO staging system. In 2018, the prior 2014 FIGO staging system was revised to incorporate imaging and pathological findings, when available, into the new staging system (Table 1) [1]. Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri are discussed by gynecologic oncologists, radiation oncologists, radiologists, pathologists, and epidemiologists in this manuscript (Table 2).

참고문헌 (Reference)

1 Matsuo K, "Validation of the 2018 FIGO cervical cancer staging system" 2018

2 Amendola MA, "Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States : results of intergroup protocol ACRIN 6651/GOG 183" 23 : 7454-7459, 2005

3 Atri M, "Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer : results of ACRIN6671/GOG0233 trial" 142 : 413-419, 2016

4 Harvey M, "The size of the cervix and its relationship with age and parity" 29 : 171-174, 2016

5 Chen T, "Survival of cervical cancer patients in Germany in the early 21st century : a period analysis by age, histology, and stage" 51 : 915-921, 2012

6 Melamed A, "Survival after minimally invasive radical hysterectomy for early-stage cervical cancer" 379 : 1905-1914, 2018

7 Balleyguier C, "Staging of uterine cervical cancer with MRI : guidelines of the European Society of Urogenital Radiology" 21 : 1102-1110, 2011

8 Landoni F, "Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer" 350 : 535-540, 1997

9 Nishio S, "Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer" 9 : 32321-32330, 2018

10 Sarker A, "Prognostic implications of the SUVmax of primary tumors and metastatic lymph node measured by 18F-FDG PET in patients with uterine cervical cancer : a meta-analysis" 41 : 34-40, 2016

11 Zighelboim I, "Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy" 24 : 625-630, 2006

12 Ramirez PT, "Minimally invasive versus abdominal radical hysterectomy for cervical cancer" 379 : 1895-1904, 2018

13 Pandharipande PV, "MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy : decision analysis to assess patient outcomes" 192 : 802-814, 2009

14 Grigsby PW, "Lymph node staging by positron emission tomography in patients with carcinoma of the cervix" 19 : 3745-3749, 2001

15 Kidd EA, "Lymph node staging by positron emission tomography in cervical cancer : relationship to prognosis" 28 : 2108-2113, 2010

16 Gee MS, "Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT : analysis from the ACRIN 6671/GOG 0233 multicenter trial" 287 : 176-184, 2018

17 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018

18 FIGO Committee on Gynecologic Oncology, "FIGO staging for carcinoma of the vulva, cervix, and corpus uteri" 125 : 97-98, 2014

19 Bhatla N, "FIGO cancer report 2018" 143 (143): 2-3, 2018

20 Xiyi Jiang, "Epidemiology of gynecologic cancers in China" 대한부인종양학회 29 (29): 1-7, 2018

21 Epstein E, "Early-stage cervical cancer : tumor delineation by magnetic resonance imaging and ultrasound-a European multicenter trial" 128 : 449-453, 2013

22 Mitchell DG, "Early invasive cervical cancer : tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 intergroup study" 24 : 5687-5694, 2006

23 Choi HJ, "Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis" 101 : 1471-1479, 2010

24 National Comprehensive Cancer Network, "Cervical cancer"

25 Bhatla N, "Cancer of the cervix uteri" 143 (143): 22-36, 2018

26 Ferlay J, "Cancer incidence and mortality patterns in Europe : estimates for 40 countries in 2012" 49 : 1374-1403, 2013

27 Siegel CL, "ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix" 9 : 395-402, 2012